Nature, Published online: 25 June 2025; doi:10.1038/s41586-025-09191-9

Using viral barcode tracing to detect interactions between glioblastoma cells and non-malignant astrocytes in patient samples, investigators discovered a pathway that reduces tumour-specific immunity and identified potential therapeutic targets.